| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/19/2001 | WO2001051654A2 Methods and kits for identifying elite event gat-zm1 in biological samples |
| 07/19/2001 | WO2001051653A1 Pcr-based detection of rhizoctonia cerealis |
| 07/19/2001 | WO2001051652A2 Method for identifying a mark applied on a solid body |
| 07/19/2001 | WO2001051651A2 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 07/19/2001 | WO2001051647A2 Method for increasing the content of fatty acids in plants and micro-organisms |
| 07/19/2001 | WO2001051646A2 Methods for producing a polypeptide using a crippled translational initiator sequence |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051644A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN Cν3 AND Cν4 DOMAINS |
| 07/19/2001 | WO2001051643A1 Mutant apre promoter |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051640A2 Regulation of human mitochondrial transformylase |
| 07/19/2001 | WO2001051639A2 Everninomicin biosynthetic genes |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051637A1 Specific fruit- plant promoter |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051634A1 Human olfactory receptor and polynucleotides encoding the same |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051632A2 Odorant receptor polypeptides and nucleic acids encoding same |
| 07/19/2001 | WO2001051631A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 07/19/2001 | WO2001051630A1 Antisense compositions and methods |
| 07/19/2001 | WO2001051629A2 Circularly permutated, interaction-activated proteins |
| 07/19/2001 | WO2001051626A2 Novel plasmid expression vectors |
| 07/19/2001 | WO2001051623A1 Cod uracil-dna glycosylase, gene coding therefore, recombinant dna containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling pcr |
| 07/19/2001 | WO2001051622A2 P450 monooxygenases of the cyp79 family |
| 07/19/2001 | WO2001051621A2 Dna polymerase mutant having one or more mutations in the active site |
| 07/19/2001 | WO2001051620A2 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 07/19/2001 | WO2001051619A2 Genetically modified fibroblast cell |
| 07/19/2001 | WO2001051616A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 07/19/2001 | WO2001051611A1 Cell production |
| 07/19/2001 | WO2001051610A1 Ectoderm cell production |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051606A2 Cell line for preparing and producing ovine adenovirus vectors |
| 07/19/2001 | WO2001051604A2 Methods for identifying anti-cancer drug targets |
| 07/19/2001 | WO2001051601A2 Methods for the storage and synthesis of nucleic acids |
| 07/19/2001 | WO2001051523A2 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051519A2 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels |
| 07/19/2001 | WO2001051518A2 Nucleic acids encoding human semaphorin proteins and use thereof |
| 07/19/2001 | WO2001051516A2 Fusion proteins for stimulating cytotoxic t-cells |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051514A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051507A1 Novel peptide and screening method by using the same |
| 07/19/2001 | WO2001051503A1 Polynucleotides for inhibiting metastasis and tumor cell growth |
| 07/19/2001 | WO2001051502A1 Improved synthesis of sulfurized oligonucleotides |
| 07/19/2001 | WO2001051500A1 Oligodeoxynucleotide and its use to induce an immune response |
| 07/19/2001 | WO2001051080A2 Methods and compositions for obtaining disease protection for animals |
| 07/19/2001 | WO2001051045A2 Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia |
| 07/19/2001 | WO2001051006A2 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | WO2001050865A2 Synergistic insect control |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001050847A2 Reca / rad51 recombinase-mediated production of recombinant organisms |
| 07/19/2001 | WO2001050829A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001012133A3 Cosmetic compositions with self-warming component |
| 07/19/2001 | WO2001009302A3 Agrobacterium-mediated plant transformation method |
| 07/19/2001 | WO2001007585A8 Electrical impedance tomography to control electroporation |
| 07/19/2001 | WO2001006007A3 Method for the identification of a receptor |
| 07/19/2001 | WO2001005994A3 Method for introducing a substance into a cell |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005935A3 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2001004331A3 Enhanced expression of proteins using gfp |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2001002549A3 Homomeric and heteromeric ampa receptors |
| 07/19/2001 | WO2001002020A3 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 07/19/2001 | WO2001000870A3 Method for comparing expression patterns of genes |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/19/2001 | WO2000078922A3 Acid-inducible promoters for gene expression |
| 07/19/2001 | WO2000077043A3 Dna vaccines for pets and sport animals |
| 07/19/2001 | WO2000073431B1 Methods and compositions for measuring ion channel conductance |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000071716A3 Vascular endothelial growth factor dimers |
| 07/19/2001 | WO2000071703A3 Inhibition of histone deacetylase |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000065053A3 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma |
| 07/19/2001 | WO2000065040A3 Cell cycle genes from plants and methods of use |
| 07/19/2001 | WO2000058516A3 Universal arrays |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000052146A3 Encryption of traits using split gene sequences |
| 07/19/2001 | WO2000044782A3 Ewing's tumour antigen, nucleic acid and antibodies |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | WO2000039280A3 Leukocyte-derived interferon preparations |
| 07/19/2001 | WO2000032824A9 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010009040 Introducing expression cassette comprising coding for fumonisin esterase enzyme and identifying transformed/ surviving plant cells |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008905 Administering a compound such as hydroxyurea to deplete the intracellular pool of deoxyribonucleoside phosphate |
| 07/19/2001 | US20010008882 Process of delivering a polynucleotide into a parenchymal cell |
| 07/19/2001 | US20010008881 Method for the augmentation of gene expression |
| 07/19/2001 | US20010008772 Lipid, nucleic acid complex |
| 07/19/2001 | US20010008771 Chimerical peptide-nucleic acid fragment, process for producing the same and its for appropriately introducing nucleic acids into cell organelles and cells |
| 07/19/2001 | US20010008770 Biocatalyst for petrochemicals; genetic engineered nucleic acid |
| 07/19/2001 | US20010008762 Electrode capture of nucleic acid |
| 07/19/2001 | US20010008759 Contacting target cells with member of antibody phage display library |